Condition
Hypophosphatasia (HPP) clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Hypophosphatasia (HPP) clinical trials that are recruiting, at sites in 4 countries (most in Germany (1), New Zealand (1), United Kingdom (1)). 1 was first registered in the last 30 days. By phase: Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1New in 30 days
- 4Countries
All recruiting trials (2)
-
Understanding the disease burden of hypophosphatasia in Chinese patients
This study tests how hypophosphatasia affects people in China by collecting real-world data on symptoms, quality of life, and costs.
-
ALE1 safety, dosing, and activity in adults with and without hypophosphatasia
Researchers will try different doses of ALE1 to check safety and how the drug acts in healthy adults and adults with hypophosphatasia.
Quick answers
How many Hypophosphatasia (HPP) clinical trials are recruiting right now?
2, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in Germany (1 trial), New Zealand (1 trial), United Kingdom (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.